Ye Xin Tao, Henmi Soichiro, Buratto Edward, Haverty Mitchell C, Yerebakan Can, Fricke Tyson, Brizard Christian P, d'Udekem Yves, Konstantinov Igor E
Department of Cardiac Surgery, Royal Children's Hospital, Melbourne, Vic, Australia; Department of Paediatrics, The University of Melbourne, Melbourne, Vic, Australia; Heart Research Group, Murdoch Children's Research Institute, Melbourne, Vic, Australia.
Division of Cardiac Surgery, Children's National Heart Institute, Children's National Hospital, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
Heart Lung Circ. 2025 Sep;34(9):935-950. doi: 10.1016/j.hlc.2025.01.009. Epub 2025 Jun 18.
The optimal management strategy for symptomatic neonates with tetralogy of Fallot is unclear. We compared the outcomes of staged repair (SR) (shunt palliation followed by complete repair) and primary repair (PR) in two institutions that have each exclusively adopted one of these strategies.
We retrospectively compared 65 symptomatic neonates who underwent shunt palliation between 1993 and 2021 at the Royal Children's Hospital, Melbourne, Australia with 38 symptomatic neonates who underwent PR between 2005 and 2018 at the Children's National Hospital, Washington, USA. Median follow-up duration was 8.0 (interquartile range 2.9-13.5) years.
After the initial procedure, hospital mortality (shunt 4.6% vs PR 7.9%; p=0.50) and 5-year survival (shunt 94%; 95% confidence interval [CI] 84%-98% vs PR 89%; 95% CI 72%-96%; p=0.21) were not significantly different. The SR group had shorter durations of cardiopulmonary bypass and intensive care admission during the neonatal period, but a higher burden of unplanned re-interventions before discharge. Five-year freedom from re-interventions was not significantly different (shunt 63%; 95% CI 49%-74% vs PR 49%; 95% CI 29%-66%; p=0.13). Postoperative morbidity, mortality, and re-interventions were not significantly different among 13 propensity score-matched pairs balanced for operative weight. For neonates weighing <3 kg, PR was associated with significantly more early re-interventions.
In symptomatic neonates with tetralogy of Fallot operated at two institutions with distinct treatment protocols, no statistically significant difference in medium-term survival and re-intervention was observed between the two strategies. SR was associated with lower neonatal morbidity but more unplanned re-interventions before discharge. PR in neonates weighing <3 kg may result in more early re-interventions.
法洛四联症有症状新生儿的最佳管理策略尚不清楚。我们比较了在两个分别专门采用其中一种策略的机构中,分期修复(SR)(分流姑息术随后进行完全修复)和一期修复(PR)的结果。
我们回顾性比较了1993年至2021年在澳大利亚墨尔本皇家儿童医院接受分流姑息术的65例有症状新生儿与2005年至2018年在美国华盛顿儿童国家医院接受PR的38例有症状新生儿。中位随访时间为8.0(四分位间距2.9 - 13.5)年。
初始手术后,医院死亡率(分流4.6% vs PR 7.9%;p = 0.50)和5年生存率(分流94%;95%置信区间[CI] 84% - 98% vs PR 89%;95% CI 72% - 96%;p = 0.21)无显著差异。SR组新生儿期体外循环和重症监护住院时间较短,但出院前计划外再次干预负担较高。5年无再次干预率无显著差异(分流63%;95% CI 49% - 74% vs PR 49%;95% CI 29% - 66%;p = 0.13)。在根据手术体重平衡的13对倾向评分匹配对中,术后发病率、死亡率和再次干预无显著差异。对于体重<3 kg的新生儿,PR与显著更多的早期再次干预相关。
在两个采用不同治疗方案的机构中接受手术的法洛四联症有症状新生儿中,两种策略在中期生存率和再次干预方面未观察到统计学显著差异。SR与较低的新生儿发病率相关,但出院前计划外再次干预更多。体重<3 kg的新生儿进行PR可能导致更多早期再次干预。